396 related articles for article (PubMed ID: 30220252)
1. Neural stem cells for disease modeling and evaluation of therapeutics for Tay-Sachs disease.
Vu M; Li R; Baskfield A; Lu B; Farkhondeh A; Gorshkov K; Motabar O; Beers J; Chen G; Zou J; Espejo-Mojica AJ; Rodríguez-López A; Alméciga-Díaz CJ; Barrera LA; Jiang X; Ory DS; Marugan JJ; Zheng W
Orphanet J Rare Dis; 2018 Sep; 13(1):152. PubMed ID: 30220252
[TBL] [Abstract][Full Text] [Related]
2. Presynaptic Dysfunction in Neurons Derived from Tay-Sachs iPSCs.
Matsushita K; Numakawa T; Odaka H; Kajihara R; Soga M; Ozasa S; Nakamura K; Mizuta H; Era T
Neuroscience; 2019 Aug; 414():128-140. PubMed ID: 31283907
[TBL] [Abstract][Full Text] [Related]
3. [Molecular pathogenesis and therapeutic approach of GM2 gangliosidosis].
Tsuji D
Yakugaku Zasshi; 2013; 133(2):269-74. PubMed ID: 23370522
[TBL] [Abstract][Full Text] [Related]
4. Progranulin associates with hexosaminidase A and ameliorates GM2 ganglioside accumulation and lysosomal storage in Tay-Sachs disease.
Chen Y; Jian J; Hettinghouse A; Zhao X; Setchell KDR; Sun Y; Liu CJ
J Mol Med (Berl); 2018 Dec; 96(12):1359-1373. PubMed ID: 30341570
[TBL] [Abstract][Full Text] [Related]
5. Induced Pluripotent Stem Cells for Disease Modeling and Evaluation of Therapeutics for Niemann-Pick Disease Type A.
Long Y; Xu M; Li R; Dai S; Beers J; Chen G; Soheilian F; Baxa U; Wang M; Marugan JJ; Muro S; Li Z; Brady R; Zheng W
Stem Cells Transl Med; 2016 Dec; 5(12):1644-1655. PubMed ID: 27484861
[TBL] [Abstract][Full Text] [Related]
6. Highly phosphomannosylated enzyme replacement therapy for GM2 gangliosidosis.
Tsuji D; Akeboshi H; Matsuoka K; Yasuoka H; Miyasaki E; Kasahara Y; Kawashima I; Chiba Y; Jigami Y; Taki T; Sakuraba H; Itoh K
Ann Neurol; 2011 Apr; 69(4):691-701. PubMed ID: 21520232
[TBL] [Abstract][Full Text] [Related]
7. GM2 ganglioside accumulation causes neuroinflammation and behavioral alterations in a mouse model of early onset Tay-Sachs disease.
Demir SA; Timur ZK; Ateş N; Martínez LA; Seyrantepe V
J Neuroinflammation; 2020 Sep; 17(1):277. PubMed ID: 32951593
[TBL] [Abstract][Full Text] [Related]
8. A pathogenic HEXA missense variant in wild boars with Tay-Sachs disease.
Bertani V; Prioni S; Di Lecce R; Gazza F; Ragionieri L; Merialdi G; Bonilauri P; Jagannathan V; Grassi S; Cabitta L; Paoli A; Morrone A; Sonnino S; Drögemüller C; Cantoni AM
Mol Genet Metab; 2021 Jul; 133(3):297-306. PubMed ID: 34119419
[TBL] [Abstract][Full Text] [Related]
9. iPS-derived neural stem cells for disease modeling and evaluation of therapeutics for mucopolysaccharidosis type II.
Hong J; Cheng YS; Yang S; Swaroop M; Xu M; Beers J; Zou J; Huang W; Marugan JJ; Cai X; Zheng W
Exp Cell Res; 2022 Mar; 412(1):113007. PubMed ID: 34990619
[TBL] [Abstract][Full Text] [Related]
10. Murine Sialidase Neu3 facilitates GM2 degradation and bypass in mouse model of Tay-Sachs disease.
Seyrantepe V; Demir SA; Timur ZK; Von Gerichten J; Marsching C; Erdemli E; Oztas E; Takahashi K; Yamaguchi K; Ates N; Dönmez Demir B; Dalkara T; Erich K; Hopf C; Sandhoff R; Miyagi T
Exp Neurol; 2018 Jan; 299(Pt A):26-41. PubMed ID: 28974375
[TBL] [Abstract][Full Text] [Related]
11. Prenatal Diagnosis of Tay-Sachs Disease.
Zhang J; Chen H; Kornreich R; Yu C
Methods Mol Biol; 2019; 1885():233-250. PubMed ID: 30506202
[TBL] [Abstract][Full Text] [Related]
12. Neural stem cells for disease modeling of Wolman disease and evaluation of therapeutics.
Aguisanda F; Yeh CD; Chen CZ; Li R; Beers J; Zou J; Thorne N; Zheng W
Orphanet J Rare Dis; 2017 Jun; 12(1):120. PubMed ID: 28659158
[TBL] [Abstract][Full Text] [Related]
13. CRISPR/nCas9-Based Genome Editing on GM2 Gangliosidoses Fibroblasts via Non-Viral Vectors.
Leal AF; Cifuentes J; Quezada V; Benincore-Flórez E; Cruz JC; Reyes LH; Espejo-Mojica AJ; Alméciga-Díaz CJ
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142595
[TBL] [Abstract][Full Text] [Related]
14. Crystallographic structure of human beta-hexosaminidase A: interpretation of Tay-Sachs mutations and loss of GM2 ganglioside hydrolysis.
Lemieux MJ; Mark BL; Cherney MM; Withers SG; Mahuran DJ; James MN
J Mol Biol; 2006 Jun; 359(4):913-29. PubMed ID: 16698036
[TBL] [Abstract][Full Text] [Related]
15. Spontaneous appearance of Tay-Sachs disease in an animal model.
Zeng BJ; Torres PA; Viner TC; Wang ZH; Raghavan SS; Alroy J; Pastores GM; Kolodny EH
Mol Genet Metab; 2008; 95(1-2):59-65. PubMed ID: 18693054
[TBL] [Abstract][Full Text] [Related]
16. Three novel mutations in Iranian patients with Tay-Sachs disease.
Jamali S; Eskandari N; Aryani O; Salehpour S; Zaman T; Kamalidehghan B; Houshmand M
Iran Biomed J; 2014; 18(2):114-9. PubMed ID: 24518553
[TBL] [Abstract][Full Text] [Related]
17. Adeno-Associated Virus Gene Therapy in a Sheep Model of Tay-Sachs Disease.
Gray-Edwards HL; Randle AN; Maitland SA; Benatti HR; Hubbard SM; Canning PF; Vogel MB; Brunson BL; Hwang M; Ellis LE; Bradbury AM; Gentry AS; Taylor AR; Wooldridge AA; Wilhite DR; Winter RL; Whitlock BK; Johnson JA; Holland M; Salibi N; Beyers RJ; Sartin JL; Denney TS; Cox NR; Sena-Esteves M; Martin DR
Hum Gene Ther; 2018 Mar; 29(3):312-326. PubMed ID: 28922945
[TBL] [Abstract][Full Text] [Related]
18. Novel bicistronic lentiviral vectors correct β-Hexosaminidase deficiency in neural and hematopoietic stem cells and progeny: implications for in vivo and ex vivo gene therapy of GM2 gangliosidosis.
Ornaghi F; Sala D; Tedeschi F; Maffia MC; Bazzucchi M; Morena F; Valsecchi M; Aureli M; Martino S; Gritti A
Neurobiol Dis; 2020 Feb; 134():104667. PubMed ID: 31682993
[TBL] [Abstract][Full Text] [Related]
19. Autophagic flux is impaired in the brain tissue of Tay-Sachs disease mouse model.
Sengul T; Can M; Ateş N; Seyrantepe V
PLoS One; 2023; 18(3):e0280650. PubMed ID: 36928510
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
